COHEN YUVAL (Chief Executive Officer) received a stock award from CORBUS PHARMACEUTICALS HOLDINGS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/16/2026ACC: 0001193125-26-015426
DirectorOfficer· Chief Executive Officer
Since Jan 2019
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
200K acquired
Non-Derivative Transactions1
Common Stock, par value $0.0001 per share
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
36.2%
1/14/2026
138.19K→188.19K
Total
Net shares
+50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 1/14/2026 | A · Award | +50K | — | — | 36.2% | 138.19K | 188.19K |
| Total | +50K | $0.00 | ||||||
Derivative Transactions1
Stock options (right to buy)
Direct
Converts to
Common Stock
150K shares
Shares
+150K
Strike price
8.26
Held after
150K
Exercisable
—
1/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock options (right to buy) Direct | Common Stock150K shares | 1/14/2026 | A · Award | +150K | 8.26 | — | 150K |